Search research articles
Contact Us
Filters
Showing results (541-550 of 829) with videos related to
Page
of 83
Sort By:
Cancer Research
|
October 1, 1991
Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity
G H Mickisch, T Licht, G T Merlino, et al.
Cancer Research
|
January 1, 1992
Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium
K Chang, L H Pai, J K Batra, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1979
Epidermal growth factor stimulation of DNA synthesis is potentiated by compounds that inhibit its clustering in coated pits
F R Maxfield, P J Davies, L Klempner, et al.
Bioconjugate Chemistry
|
January 1, 1993
Affinity purification and characterization of anti-Tac(Fv)-C3-PE38KDEL: A highly potent cytotoxic agent specific to cells bearing IL-2 receptors
C Spence, M Nachman, M K Gately, et al.
Molecular Medicine (Cambridge, Mass.)
|
April 26, 2000
Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein
T K Bera, P E Kennedy, E A Berger, et al.
The Journal of Biological Chemistry
|
March 5, 1993
Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells
E A Mesri, R J Kreitman, Y M Fu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1982
The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection
C M Gorman, G T Merlino, M C Willingham, et al.
Cancer Research
|
June 1, 1991
Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin
R K Puri, M Ogata, P Leland, et al.
Bioconjugate Chemistry
|
January 1, 1992
Rational design of a chimeric toxin: an intramolecular location for the insertion of transforming growth factor alpha within Pseudomonas exotoxin as a targeting ligand
R J Kreitman, V K Chaudhary, C B Siegall, et al.
Bioconjugate Chemistry
|
January 1, 1992
Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor alpha at different locations in Pseudomonas exotoxin
R J Kreitman, C B Siegall, V K Chaudhary, et al.
Page
of 83
Search research articles
Search
Showing results (541-550 of 829) with videos related to
Sort By:
Page
of 83
Cancer Research
|
October 1, 1991
Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity
G H Mickisch, T Licht, G T Merlino, et al.
Cancer Research
|
January 1, 1992
Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium
K Chang, L H Pai, J K Batra, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1979
Epidermal growth factor stimulation of DNA synthesis is potentiated by compounds that inhibit its clustering in coated pits
F R Maxfield, P J Davies, L Klempner, et al.
Bioconjugate Chemistry
|
January 1, 1993
Affinity purification and characterization of anti-Tac(Fv)-C3-PE38KDEL: A highly potent cytotoxic agent specific to cells bearing IL-2 receptors
C Spence, M Nachman, M K Gately, et al.
Molecular Medicine (Cambridge, Mass.)
|
April 26, 2000
Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein
T K Bera, P E Kennedy, E A Berger, et al.
The Journal of Biological Chemistry
|
March 5, 1993
Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells
E A Mesri, R J Kreitman, Y M Fu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1982
The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection
C M Gorman, G T Merlino, M C Willingham, et al.
Cancer Research
|
June 1, 1991
Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin
R K Puri, M Ogata, P Leland, et al.
Bioconjugate Chemistry
|
January 1, 1992
Rational design of a chimeric toxin: an intramolecular location for the insertion of transforming growth factor alpha within Pseudomonas exotoxin as a targeting ligand
R J Kreitman, V K Chaudhary, C B Siegall, et al.
Bioconjugate Chemistry
|
January 1, 1992
Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor alpha at different locations in Pseudomonas exotoxin
R J Kreitman, C B Siegall, V K Chaudhary, et al.
Page
of 83